Becton, dickinson and company:1106636 [25-003202] reagent kits to investigate new targets for the treatment of substance use disorders with cell-specificity resolution in support of ongoing research…
Ended Purchase Order Awarded Last action
- Contract number
- 75N95025P00325
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,617
Award facts
- Contract value 100% obligated
- $18,617.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency, to Becton, Dickinson and Company (BD) for $18,617.35. The contract is for the supply of reagent kits to investigate new targets for the treatment of substance use disorders with cell-specificity resolution, in support of the agency's ongoing research experiments. The contract does not have a set-aside designation, indicating BD competed for the award as a large, established medical technology manufacturer. BD is a global provider of specialized flow cytometry equipment, cell imaging technologies, and genomics solutions to federal agencies. The company has a long-standing relationship with government research and healthcare institutions, holding several significant federal contract Indefinite Delivery Vehicles across agencies like the Department of Veterans Affairs and National Institutes of Health.
Description
Becton, dickinson and company:1106636 [25-003202] reagent kits to investigate new targets for the treatment of substance use disorders with cell-specificity resolution in support of ongoing research experiments.
Quick answers
Who was awarded contract 75N95025P00325?
75N95025P00325 was awarded to Becton, Dickinson And Company by National Institute on Drug Abuse (National Institutes of Health) on July 18, 2025.
How much is contract 75N95025P00325 worth?
The government has obligated $18,617 on 75N95025P00325.
Was contract 75N95025P00325 competed?
The extent of competition for 75N95025P00325 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award